Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

NOVARTIS AG (NOVN)

148
Delayed Quote. Delayed BATS Europe - 08/20 11:30:00 am
80.725 CHF   +0.53%
12h ago NOVARTIS : provides drug candidate compounds to TB Alliance »
13h ago NOVARTIS : provides drug candidate compounds to TB Alliance
1d ago NOVARTIS : Alcon Research Assigned Patent
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Latest news on NOVARTIS AG
12h ago NOVARTIS : provides drug candidate compounds to TB Alliance »
13h ago NOVARTIS : provides drug candidate compounds to TB Alliance
1d ago NOVARTIS : Alcon Research Assigned Patent
1d ago NOVARTIS : National Association of Professional Women Announces Georgina Wood, D..
2d ago NOVARTIS : Health and Human Services Department (HHS); Food and Drug Administrat..
2d agoDJZurich Stocks Mostly Higher; Swisscom Down -- Market Talk
2d ago NOVARTIS : Merus Labs Posts 3rd Quarter FY 2014 Financial Results
3d ago NOVARTIS : MILITARY Wave Cards Sought by U.S. Army
4d ago ANACOR PHARMACEUTICALS : Posts Second Quarter 2014 Financial Results
6d ago NOVARTIS : Patent Issued for Coherent and Non-Coherent Interferometry with Cold ..
7d ago NOVARTIS' : Trademark Application for "DON'T LET HEADACHES STEAL YOUR DREAMS" Fi..
7d ago NOVARTIS' : Trademark Application for "A SERIOUS OPTION FOR SERIOUS QUITTERS" Fi..
7d ago NOVARTIS' : Trademark Application for "STOP CRAVING, START SAVING" Filed
7d ago NOVARTIS : An Application for the Trademark "NICOTINELL" Has Been Filed by Novar..
7d ago NOVARTIS : An Application for the Trademark "CRAVE LIFE, NOT CIGARETTES" Has Bee..
7d ago ENANTA PHARMACEUTICALS' : HCV NS5A Inhibitor EDP-239 Advances into Combination S..
7d ago ANACOR PHARMACEUTICALS : Reports Second Quarter 2014 Financial Results
7d ago NOVARTIS : lead a tight division
08/13 NOVARTIS : Merus Labs International Announces Third Quarter Results for Fiscal 2..
08/12 NOVARTIS : Presolicitation Notice - 65-- Alcon Allegretto Wave Cards
08/12 ANACOR PHARMACEUTICALS : Releases Second Quarter 2014 Financial Results
08/11 NOVARTIS : Health and Human Services Department (HHS); Food and Drug Administrat..
08/11 NOVARTIS : US District Court Says DOJ Can Continue False Claims Act Case Against..
08/11 NOVARTIS : to showcase heart failure leadership at ESC Congress 2014 with result..
08/08 NOVARTIS : Heart Failure Drug LCZ696 To Be A Multibillion-Dollar Seller, Two Sur..
08/07 NOVARTIS : loses new bid to dismiss U.S. lawsuit over kickbacks
08/07 Novartis loses new bid to dismiss U.S. lawsuit over kickbacks
08/07 BUSINESS MACHINES : IBM Chosen to Manage Global SAP Infrastructure for Leading S..
08/06 NOVARTIS : Trademark Application for "VOLTAFLEX" Filed by Novartis
08/06 NOVARTIS : Trademark Application for "GASX" Filed by Novartis
08/06 NOVARTIS' : Trademark Application for "MEDICINE OF MOTHERHOOD" Filed
08/06 NOVARTIS : Trademark Application for "A SERIOUS OPTION FOR SERIOUS QUITTERS" Fil..
08/06 NOVARTIS : "Pulmonary Delivery of Aminoglycoside" in Patent Application Approval..
08/06 NOVARTIS : Jaguars keep up promotion charge with victory
08/06 OPHTHOTECH : Reports Second Quarter 2014 Financial Results and Provides Business..
08/05 NOVARTIS : announces NEJM publication of two phase III studies demonstrating hig..
08/04 NOVARTIS : Health and Human Services Department (HHS); Food and Drug Administrat..
08/04 NOVARTIS : Alcon Research Assigned Patent
08/01 Pfizer bid for GSK 'has some merits', says Berenberg
08/01DJLONDON MARKETS : FTSE 100 Slumps For Third Day As Miners, Banks Slump
08/01 Incyte Reports 2014 Second-Quarter Financial Results and Updates Shareholders..
08/01DJP&G to Shed More Than Half Its Brands
07/31 NOVARTIS : "Plunger Tip Coupling Device for Intraocular Lens Injector" in Patent..
07/31 Bench International Appoints Dr Sally Barennes as Vice President, Executive R..
07/31 NOVARTIS : KAE609 shows promise as next generation treatment for malaria
07/31 NOVARTIS : Oxford University - Promising results in efforts to develop new malar..
07/31 NOVARTIS : KAE609 shows promise as next generation treatment for malaria »
07/31 ATLAS COPCO : Updates on Sandoz Mumbai Project
07/31 NOVARTIS : Trademark Application for "MEDICINE OF MOTHERHOOD" Filed by Novartis
07/31 NOVARTIS' : Trademark Application for "A SERIOUS OPTION FOR SERIOUS QUITTERS" Fi..
07/31 NOVARTIS : An Application for the Trademark "VOLTAFLEX" Has Been Filed by Novart..
07/31 NOVARTIS : An Application for the Trademark "GASX" Has Been Filed by Novartis
07/31 ANACOR PHARMACEUTICALS : and Sandoz Enter Into an Agreement for the Commercializ..
07/30 NOVARTIS : Patent Issued for Powder Filling Apparatus and Methods for Their Use
07/30 NOVARTIS : Patent Issued for Contact Lenses Containing Carotenoid and Method for..
07/30 NOVARTIS : continue charge at the top ; Midweek Divisions 4-6 sport@grimsbyteleg..
07/30 NOVARTIS : KAE609 shows promise as next generation treatment for malaria
07/30 NOVARTIS : Researchers Submit Patent Application, "Compounds for the Treatment o..
07/30 GOOGLE 'C' : contact lenses closer to reality
07/30 AstraZeneca buys Almirall lung drugs for up to $2.1 billion
07/30 ATLAS COPCO : Reports Sandoz Mumbai Project
07/29 Despite strains, GlaxoSmithKline dividend seen safe for now
07/29 NOVARTIS : Alcon's Simbrinza approved in the EU to treat patients living with gl..
07/29 NOVARTIS : vaccine Bexsero sees high uptake in first large-scale public vaccinat..
07/29 NOVARTIS : vaccine Bexsero® sees high uptake in first large-scale public vaccina..
07/29 NOVARTIS INDIA : NET RISES 3% AT Rs14.31 CRORE
07/29 NOVARTIS : vaccine Bexsero® sees high uptake in first large-scale public vaccina..
07/28 NOVARTIS : Health and Human Services Department (HHS); Food and Drug Administrat..
07/28DJNOVARTIS : Gets EU Approval For Glaucoma Drug
07/28 NOVARTIS : Alcon's Simbrinza® approved in the EU to treat patients living with g..
07/28 NOVARTIS : Alcon's Simbrinza® approved in the EU to treat patients living with g..
07/26 NOVARTIS : Discover how different regions approach and manage Market Access & HT..
07/25DJDrug Companies Oppose Moves to Reimburse Off-Label Medicine
07/24 NOVARTIS : Researchers Submit Patent Application, "Iol with Varying Correction o..
07/24 NOVARTIS : FDA accepts Sandoz application for biosimilar filgrastim »
Prev.1   2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Novartis AG Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Income Statement Evolution
Novartis AG : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF